Iuri Estrada Gouvea

Iuri Estrada Gouvea

Auto-generated profile, based on publicly available information

Iuri Estrada Gouvea

Biophysics of Universidade Federal de São Paulo, São Paulo, SP, 04024-002, Brazil.

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SASheila Andrade
Sheila Andrade
IGIuri Estrada Gouvea
Iuri Estrada Gouvea
MSMariana Cristina C. Silva
Mariana Cristina C. Silva
ECEloísa Dognani Castro
Eloísa Dognani Castro
CPCláudia A. A. de Paula
Cláudia A. A. de Paula
MGManoel J. B. C. Girão
Manoel J. B. C. Girão
Breast cancer comprises clinically and molecularly distinct tumor subgroups that differ in cell histology and biology and show divergent clinical phenotypes that impede phase III trials, such as those utilizing cathepsin K inhibitors. Here we correlate the epithelial-mesenchymal-like transition breast cancer cells and cathepsin K secretion with activation and aggregation of platelets. Cathepsin K is up-regulated in cancer cells that proteolyze extracellular matrix and contributes to invasiveness. Although proteolytically activated receptors (PARs) are activated by proteases, the direct interaction of cysteine cathepsins with PARs is poorly understood. In human platelets, PAR-1 and −4 are highly expressed, but PAR-3 shows low expression and unclear functions. Platelet aggregation was monitored by measuring changes in turbidity. Platelets were immunoblotted with anti-phospho and total p38, Src-Tyr-416, FAK-Tyr-397, and TGFβ monoclonal antibody. Activation was measured in a flow cytometer and calcium mobilization in a confocal microscope. Mammary epithelial cells were prepared from the primary breast cancer samples of 15 women with Luminal-B subtype to produce primary cells. We demonstrate that platelets are aggregated by cathepsin K in a dose-dependent manner, but not by other cysteine cathepsins. PARs-3 and −4 were confirmed as the cathepsin K target by immunodetection and specific antagonists using a fibroblast cell line derived from PARs deficient mice. Moreover, through co-culture experiments, we show that platelets activated by cathepsin K mediated the up-regulation of SHH, PTHrP, OPN, and TGFβ in epithelial-mesenchymal-like cells from patients with Luminal B breast cancer. Cathepsin K induces platelet dysfunction and affects signaling in breast cancer cells.

1 March 2014 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
DODébora N. Okamoto
Débora N. Okamoto
MKMarcia Y. Kondo
Marcia Y. Kondo
LOLilian Caroline Gonçalves Oliveira
Lilian Caroline Gonçalves Oliveira
RHRodrigo V. Honorato
Rodrigo V. Honorato
LZLeticia M. Zanphorlin
Leticia M. Zanphorlin
IGIuri E. Gouvea
Iuri E. Gouvea